Alden Kandic

Alden Kandic is a seasoned professional in quality assurance and management within the pharmaceutical industry, currently serving as the Head of Quality and Vice President at Procella Therapeutics AB since May 2022. Prior experience includes leadership roles at Sobi - Swedish Orphan Biovitrum AB (publ) from November 2013 to May 2022, where Alden held multiple positions including Head of QA Haematology, Qualified Person, and Director of QA for Haemophilia. Additional experience encompasses quality assurance roles at Crucell Sweden AB, Apoteket Produktion & Laboratorier, and Diamyd Medical. Alden Kandic holds a Master of Science degree from Mälardalen University, completed in 2009.